http://www.onemedplace.com/blog/wp-content/uploads/2010/03/pills_credit_card.jpg

Delcath's Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient's entire body to the anti-cancer drugs.